Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
She has been reporting on health and medicine since 2015.
- Simplified Text
-
She has been reporting on health and medicine since 2015
- Confidence Score
- 0.950
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "person_covered": "Rebecca Robbins", "reporting_area": "health and medicine", "reporting_start_year": "2015" } - Subject Tags
- UUID
- a1164c08-186c-4fce-ae1d-b0be5ced131b
- Vector Index
- ✗ No vector
- Created
- February 15, 2026 at 4:02 PM (8 months ago)
- Last Updated
- February 15, 2026 at 4:02 PM (8 months ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
30
claims
🔥
1 month ago
https://nytimes.com/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html
The FDA rejected Moderna's mRNA flu vaccine, signaling a shift in federal health policy under Health Secretary Robert F. Kennedy Jr. The rejection is based on concerns about the clinical trial's comparison product. Moderna's stock has plummeted since its peak.
Similar Claims (5)
Other claims identified as semantically similar to this one.
-
Simplified: Rebecca Robbins is a Times reporter covering the pharmaceutical industry8 months ago
-
Simplified: Rebecca Tauber previously worked at Denverite and Colorado Public Radio.4 weeks ago
-
Simplified: Joseph Goldstein covers health care in New York for The Times following years of criminal justice and police reporting8 months ago
-
Simplified: Rebecca Tauber grew up in Lower Merion, Pa., and graduated from Williams College.4 weeks ago
-
Simplified: Rebecca Tauber is a Senior Editor on The Athletic’s news team.4 weeks ago